No abstract available
MeSH terms
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Cost-Benefit Analysis
-
Herpes Zoster / etiology
-
Herpes Zoster / prevention & control*
-
Herpes Zoster Vaccine / administration & dosage*
-
Herpes Zoster Vaccine / economics
-
Humans
-
Middle Aged
-
Neuralgia, Postherpetic / prevention & control*
-
Vaccines, Attenuated / administration & dosage
-
Vaccines, Synthetic / administration & dosage
Substances
-
Herpes Zoster Vaccine
-
Vaccines, Attenuated
-
Vaccines, Synthetic